Oximio, South Africa, is delighted to announce that it has secured a resolution to the SAHPRA (South African Health Products Regulatory Authority) licence for the handling of medical cannabis. This marks a significant milestone in the company’s journey and means that...

Our customers are at the heart of everything we do. Listening carefully to their needs and delivering an outstanding service, backed with excellent customer support, is key to building successful relationships and indeed, a successful business.  Our annual survey...

At Oximio, we recognise the pivotal role our staff play in our success and growth. Our dedicated team is the backbone of our organisation, and their collective skills, expertise, and passion are instrumental in driving us forward. We firmly believe that fostering a...

The swift and stable delivery of bio-samples is critical in clinical trials to ensure that samples maintain their original state and remain in pristine condition upon arrival at their destination. This allows for precise examination and analysis. Oximio, Ukraine,...

The need to bridge the gap between essential medicines and their accessibility can mean the difference between success and failure for any clinical trial. This was the problem that faced a local medical facility in South Africa when multiple pallets of vital supplies...

Following successful audits in May, Oximio is delighted to announce the expansion of its partner network with two new contracted depots in Croatia and the UK. These will further expand our global reach and the end-to-end supply chain solutions for the clinical trials...

Oximio is delighted to announce its sponsorship of the inaugural launch of the Clinical Research Society of Kenya (CRSK) on 8th June in Nairobi. The CRSK is a non-profit organization set up to represent the clinical research community in Kenya. Acting as a...